Abstract
This chapter discusses the role of chemistry within the pharmaceutical industry. Although the focus is upon the industry within the United States, much of the discussion is equally relevant to pharmaceutical companies based in other nations, for example Japan and those in Europe. The primary objective of the pharmaceutical industry is the discovery, development, and marketing of safe and efficacious drugs for the treatment of human disease. However, drug companies must earn profits in order to remain viable and finance the essential research and development that leads to new drugs designed to address unmet medical need. Thus, there exists a tension between the dual goals of enhancing the quality and duration of human life and increasing stockholder or private investor equity. The chapter provides an overview of the processes and activities involved in drug discovery and development with an emphasis on the role of chemists. Examples of marketed drugs are provided and are organized by the major disease areas. Several important drug discovery strategies and technologies that may be employed when applicable are briefly summarized. A section on process chemistry provides an overview of the topic and then describes some recent actual examples. Despite the considerable benefits provided by therapeutic agents discovered to date, there remains considerable unmet medical need in many disease areas. Pharmaceutical research will continue to be challenging but it is anticipated that creative medicinal, analytical, and process chemists will be needed at the forefront to enable the future discovery of new medicines and to bring improvements to the overall effectiveness of the field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Krogsgaard-Larsen, P., Liljefors, T., Madsen, U. (Eds.) (1996) A textbook of drug design and development, 2, Harwood Academic, Amsterdam.
Spilker B (1989) Multinational drug companies; issues in drug discovery and development. Raven Press, New York
Wermuth CG (ed) (1996) The practice of medicinal chemistry. Academic, San Diego
Wess G, Urmann M, Sickenberger B (2001) Angew Chem Int Ed 40:3341–3350
Lipinski CA, Lombardo F, Dominy DW, Feeny PJ (1997) Adv Drug Deliv Rev 23:3–25
Stella VJ, Borchardt RT, Hageman MJ, Oliyai R, Maag H, Tilley JW (eds) (2007) Prodrugs: challenges and rewards, Parts 1 and 2. Springer, New York
Gauwerky K, Borelli C, Korting HC (2009) Drug Discov Today 14:214–222
Miertus S, Fassina G (eds) (1999) Combinatorial chemistry and technology: principles, methods and applications. Marcel Dekker Inc, New York
Dolle R (2001) J Combinatorial Chem 3:477–518
Franzini RM, Neri D, Scheuermann J (2014) Acc Chem Res 47:1247–1255
Musumeci F, Schenone S, Desogus A, Nieddu E, Deodato D, Botta L (2015) CurrMed Chem 22:2022–2050
See International Conference of Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guideline. Impurities in New Drug Substances Q3A (R2): (2006) High dose drugs may require lower impurity limits. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html
Laird T (2010) Org Process Res Dev 14:942–1045
See International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guideline. Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk M7: (2014) http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html
Gerberick GF, Ryan CA, Dearman RJ, Kimber I (2007) Methods 41:54–60
Gautheron P, Dukic M, Alix D, Sina J (1992) Fundam Appl Toxicol 18:442–449
Leonhardt J, Nau M, Wolter M, Rau CJ (2008) Prev Process Ind 21:400–406
Urben PG (ed) (2007) Bretherick’s handbook of reactive chemical hazards. Butterworth-Heinemann LTD, Jordan Hill, Oxford
Pratt, Thomas H. (July 15, 1997). Electrostatic ignitions of fires and explosions, Wiley-AIChE Center for Chemical Process Safety
Gastroplus is a software application from Simulations Plus, Inc., Lancaster, Ca. which simulates a range of properties including absorption, pharmacokinetics and pharmacodynamics in both animals and humans
Kopach M, Leahy D, Manley J (2012) Innovations Pharm Technol 43:72
Sá Gomes P, Rodrigues AE (2012) Chem Eng Technol 1:17–34
McConville FX (2007) The pilot plant real book, 2nd edn. FXM Engineering and Design, Worcester, MA
Purandare A, McDevitt TM, Wan H, You D, Penhallow B, Vuppugalla R, Zhang Y, Ruepp SU, Trainor GI, Lombardo L, Pedicord D, Gottardis MM, Ross-Macdonald P, de Silva H, Hosbach J, Emanuel SL, Blat Y, Fitzpatrick E, Taylor TL, McIntyre KW, Michaud E, Mulligan C, Lee FY, Woofson A, Lasho TL, Pardanani A, Tefferi A, Lorenzi MV (2012) Leukemia 26:280
Wei CS, Davies GHM, Soltani O, Albrecht J, Gao Q, Pathirana P, Hsiao Y, Tummala S, Eastgate MD (2013) Angew Chem Int Ed 52:5822–5826
Foo K, Sella E, Thomé I, Eastgate MD, Baran PS (2014) J Am Chem Soc 136:5279–5282
Beutner GL, Desai L, Fanfair D, Lobben P, Anderson E, Leung SW, Eastgate MD (2014) Org Process Res Dev 18:1812–1820
Chen K, Eastgate MD, Zheng B, Li J (2011) Org Process Res Dev 15:886–892
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Kadow, J.F., Meanwell, N.A., Eastman, K.J., Yeung, KS., DelMonte, A.J. (2017). Chemistry in the Pharmaceutical Industry. In: Kent, J., Bommaraju, T., Barnicki, S. (eds) Handbook of Industrial Chemistry and Biotechnology. Springer, Cham. https://doi.org/10.1007/978-3-319-52287-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-52287-6_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52285-2
Online ISBN: 978-3-319-52287-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)